Square Face: Masseter, Bone or Fat? How to Assess

"My face is square" is one of the most frequent concerns about the lower third, and one of the most prone to a wrong indication. The patient arrives asking for toxin in the masseter because they saw somewhere that it "slims the face," but a wide, angular contour can come from four different sources: muscle, bone, fat or gland. Toxin acts only on the first.

This guide covers the differential diagnosis. The indication, timeline and risks of toxin in the masseter are already in botulinum toxin in the masseter and are not repeated here. Nothing in this text is a protocol: the approach is the decision of the qualified practitioner, according to the rules of their professional board.

What makes a face look square?

In the front view, a face looks square when the width at the jaw angles approaches the width at the cheekbones, with a straight jawline and a pronounced mandibular angle. A broad forehead and a broad chin reinforce the impression.

It is not a defect. It is a shape, common in people with a more horizontal pattern of facial growth and strong chewing muscles, and highly valued in the male face. The question for the assessment is not "how do I slim it" but "what is creating this width and does it truly bother the patient." Reading the whole face, in thirds, avoids treating the lower third in isolation.

What are the four causes to separate?

In practice, the causes add up. A patient with a strong masseter may also have a wide bony angle and some fat. The role of the assessment is to estimate how much of each there is, so you can say honestly what a procedure can and cannot change.

How do you assess the masseter?

The masseter is the most frequent candidate, and also the one most often confirmed on examination. The signs that usually point to it:

• Palpation at rest and in contraction. With the patient clenching, the masseter bulges and hardens under the fingers. The difference between rest and contraction is the main clue.
• Location. The volume sits over the ramus and angle of the mandible, on the side of the lower third.
• Signs of clenching. Tooth wear, tooth marks on the edge of the tongue, a whitish line on the cheek lining, fatigue or pain when chewing, a partner's report of grinding at night.
• Functional asymmetry. Chewing more on one side can leave one masseter larger.

How do you recognize the bony component?

Bone defines the "skeleton" of the lower third: width between the angles, slope of the ramus and shape of the mandibular angle. A tighter angle and a more vertical ramus give a squarer contour. A family component and a relationship with facial type are common.

Clues that bone weighs more:

• the contour stays angular and wide with the patient relaxed, with no obvious muscle bulk;
• palpation finds a well-defined bony edge, with little tissue over it;
• the width does not change when clenching;
• old photos show the same shape since adolescence.

When doubt persists, imaging ordered by the qualified practitioner helps separate bone from soft tissue. The key point for the conversation with the patient is simple: an injectable does not reduce bone. Real bone change is a surgical matter, and referral is part of an honest assessment.

And when it is fat?

Fat gives a softer volume that changes with weight and age. It usually sits below and in front of the angle, in the area of the double chin and the fat pads of the lower third, rather than on the side of the ramus. With aging, fat that descends to the jawline can break the contour and create a "heavy" face that the patient calls square.

In these cases, reducing the masseter does not help and can worsen the look, because it removes support from an area that is already sagging. Assessing the double chin and neck has its own page: double chin: fat, laxity or bone. Cheek fat, tied to the buccal fat pad, appears more in the middle third and is another conversation, discussed in buccal fat removal or facial harmonization.

When does the parotid gland need to be remembered?

The parotid sits in front of the ear and extends backward and over the back part of the masseter. Enlargement of this gland, from inflammatory, metabolic or tumor causes, can widen the lower third and be mistaken for muscle hypertrophy.

Swelling also confuses the picture: fluid retention, dental inflammation, infection or a recent procedure can temporarily widen the lower third. Volume that appeared recently calls for a clinical history before an aesthetic plan.

How do you turn the diagnosis into a plan?

After separating the causes, the plan usually follows one of these paths, always at the discretion of the qualified practitioner:

1. Dominant muscle component and a real concern. Toxin in the masseter comes in as an option, along with managing bruxism when present.
2. Dominant bone component. Explain the limits of injectables. In some cases, balance comes from other areas: a more projected chin or a more emphasized middle third changes how the face reads without touching the width.
3. Fat and laxity. Plan from the double chin and support, without reducing the muscle.
4. Gland or suspicious volume. Refer and do not treat until diagnosed.
5. A shape the patient values. Sometimes the best indication is not to slim. In men especially, a broad lower third is often part of identity; see male orofacial harmonization.

A frequent caution: someone who wants a slimmer face and a "defined" jaw at the same time is asking for two things that pull in opposite directions. Filling the jawline defines the edge but can also widen. It is worth planning in stages and showing the patient the effect of each one.

And in Harmy?

Record in the patient record the photos at rest and in contraction, the clues for each cause and the conversation about limits. This protects the patient from a wrong expectation and you from a future complaint.

Square face checklist

1. Patient's real concern understood: width, angle, weight or asymmetry.
2. Palpation at rest and while clenching recorded.
3. Signs of bruxism investigated and referred when indicated.
4. Bony component estimated and the limits of injectables explained.
5. Fat and double chin assessed before thinking about reducing muscle.
6. Volume suspected to be gland or of recent growth referred.
7. Standardized photos from the front and at three-quarter view, at rest and in contraction.
8. Overall plan considered, including the option of not slimming.